Zero ad trackers.We never sell your data.
Home/Rare Diseases/Leigh Syndrome

Metabolic & Lysosomal

Leigh Syndrome Clinical Trials and Treatments

Also called Leigh syndrome, Leigh disease, Subacute necrotizing encephalomyelopathy, Leigh syndrome spectrum, MT-ATP6 Leigh syndrome, SURF1 deficiency, Mitochondrial Leigh syndrome

Mitochondria turn food and oxygen into the energy every cell runs on, and the brain uses more of it than any other organ. In Leigh syndrome a genetic fault in one of the energy-making steps, most often complex I or complex IV of the respiratory chain, or the pyruvate dehydrogenase enzyme, leaves nerve cells in the basal ganglia and brainstem starved of energy.

FDA-approved medicines

0

No medicine's current FDA label names Leigh Syndrome yet.

Active trials

6

5 recruiting now

Next FDA decision

None set

FDA calendar

Medicines are those whose current FDA label names Leigh Syndrome, checked October 14, 2026. Corticosteroids and immune globulins count once each. Download the data

View 6 active trialsMatch me to a trial

About Leigh Syndrome

Mitochondria turn food and oxygen into the energy every cell runs on, and the brain uses more of it than any other organ. In Leigh syndrome a genetic fault in one of the energy-making steps, most often complex I or complex IV of the respiratory chain, or the pyruvate dehydrogenase enzyme, leaves nerve cells in the basal ganglia and brainstem starved of energy. Those regions control movement, swallowing, eye movement and breathing, which is why the disease looks the way it does. On a brain MRI the damage shows up as matching bright spots on both sides of those structures, and lactate is often raised in the blood or spinal fluid, especially during an illness.

The course is usually stepwise rather than steady. A child does well for a stretch, then an infection or fever triggers a sudden decline, followed by partial recovery to a new, lower baseline. Most children have at least one of these sudden declines, which may require hospitalization, and up to half die before age 3, most often from breathing or heart failure. Some children have stable periods lasting years, and outcomes vary widely: very early onset, brainstem involvement, the MT-ATP6 m.8993T>G change and MT-ND5 changes have been linked to more severe disease, published reports on SURF1 conflict, and a small number of subtypes, such as the thiamine transporter gene SLC19A3, respond to high-dose vitamins if caught early.

Diagnosis today rests on genetic testing, usually a nuclear gene panel or whole-exome sequencing plus mitochondrial DNA sequencing that measures the mutant load, rather than the muscle biopsy or autopsy that defined the disease for decades. Care is supportive: nutrition (often by feeding tube), seizure control, avoiding the drug valproate and other metabolic stressors, and a vitamin and cofactor mix that many specialists prescribe despite limited trial evidence.

Common Symptoms of Leigh Syndrome

Recognizing the signs of Leigh Syndrome early can lead to faster diagnosis and better outcomes. Symptoms may vary in severity from person to person. If you or a loved one are experiencing any of the following, consider speaking with a specialist.

  • Vomiting, diarrhea, trouble swallowing and poor weight gain, often the first signs
  • Loss of skills a child had already learned, with floppy muscle tone
  • Stiff or twisting postures (dystonia), unsteady balance and tremor
  • Irregular breathing, with pauses or unusually fast or slow breaths, from damage to the brainstem
  • Weak eye muscles, jerky eye movements and vision loss from optic nerve damage
  • Seizures, and in some children a thickened heart muscle, hearing loss, or liver or kidney problems

Who Leigh Syndrome Affects

Symptoms usually begin in the first year of life, often appearing or sharply worsening during a fever or infection. More than 130 genes can cause it (over 120 in the nuclear DNA and 15 in the mitochondrial DNA): about 70% to 80% of cases come from nuclear genes, usually inherited from both parents (autosomal recessive, a 1 in 4 chance in each pregnancy), and roughly 20% to 30% from mitochondrial DNA, which is inherited only through the mother, though some changes arise new in the child. In mitochondrial DNA cases, the share of mutated copies (heteroplasmy) can influence severity, most clearly for the MT-ATP6 m.8993 changes. A few genes, such as PDHA1, are X-linked. A minority of people first develop symptoms as teenagers or adults, with ataxia, nerve damage or psychiatric symptoms.

Find Your Next Step

Find trials I might fit Answer a few questions and see which open Leigh Syndrome trials fit your age, location and treatment history.Get help paying Drugmaker programs and charity funds, filtered by your insurance.

Side Effect Explorer

Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.

Loading side effect data...

Questions about side effects?
I can help you understand what these reports mean
Start withor ask

Genetic Testing

Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.

Finding labs...

Trusted Leigh Syndrome Resources

Reputable organizations and medical references for learning more about Leigh Syndrome, including disease registries, foundation resources, and clinical guidelines.

Active Clinical Trials for Leigh Syndrome

Use this Leigh Syndrome clinical trial finder to see the 5 studies recruiting patients and 1 opening soon in the United States and worldwide, with eligibility criteria in plain English. Of these, 1 tests a treatment and 5 are observational studies or registries; each card says which. These studies play a critical role in advancing care for metabolic & lysosomal conditions and may offer access to treatments not yet widely available. Each trial below is sourced directly from ClinicalTrials.gov, with eligibility criteria translated into plain English to help patients and caregivers evaluate whether a study may be a fit.

New to trials? What Placebos and Randomization Actually Mean for You (In Plain English) · 4 min readWorried about cost? The Hidden Costs of Joining a Clinical Trial (And How to Get Help Paying for Them) · 4 min read
TrialsSite mapPipeline timeline

Note: Trial recruitment statuses on ClinicalTrials.gov may not immediately reflect recent FDA decisions, sponsor announcements, or enrollment changes. Always confirm a trial's current status directly with the study coordinator before making plans.

6 active trials worldwide
Filter:
Sort:
RECRUITINGObservational study, no treatment givenRecently updatedNCT01780168

The NIH MINI Study: Metabolism, Infection, and Immunity in Inborn Errors of Metabolism

Sponsor: National Human Genome Research Institute (NHGRI)

The Metabolism, Infection and Immunity (MINI) Study is a longitudinal natural history study at the National Institutes of Health (NIH) that aims to define the relationship between infection, immunity and clinical decline in individuals with mitochondrial disease. Mitochondrial di...

Ages 4 Weeks to 115 Years1 location
Started Dec 2012Updated 2 days agoEst. Dec 2099 (~73y 3m)
RECRUITINGObservational study, no treatment givenRecently updatedNCT05554835

Global Registry and Natural History Study for Mitochondrial Disorders

Sponsor: LMU Klinikum

The main goal of the project is provision of a global registry for mitochondrial disorders to harmonize previous national registries, enable world-wide participation and facilitate natural history studies, definition of outcome measures and conduction of clinical trials.

Ages not specified34 locations
Started Feb 2009Updated 2 months agoEst. Dec 2040 (~14y 2m)
NOT YET RECRUITINGTreatment trialPhase 2Recently updatedNCT06990984

A Dose-ranging Study of TTI-0102 in Adults and Children With Leigh Syndrome Spectrum (LSS)

Intervention: TTI-0102: cysteamine-pantetheine disulfide, D-Mannitol

Sponsor: Thiogenesis Therapeutics, Inc.

The goal of this clinical trial is to investigate oral TTI-0102 to evaluate its pharmacokinetics, safety, and preliminary efficacy in patients with Leigh syndrome spectrum, in three sequences. First sequence will be placebo-controlled and include 12 adolescents and adults weighin...

Ages 5 Years to 55 Years
Expected to start Oct 2026Updated 2 months agoEst. Jun 2027 (~8 months)
RECRUITINGPatient registry covering many conditionsHasn't posted an update in over a yearNCT01793168

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Sponsor: Sanford Health

CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily a...

Ages not specified2 locations
Started Jul 2010Updated 1 year agoEst. Dec 2100 (~74y 3m)
RECRUITINGObservational study, no treatment givenHasn't posted an update in over a yearNCT06967831

Drug Repurposing for Mitochondrial Disorders Using iPSCs Derived Neural Cells

Intervention: skin biopsy, generation of iPSCs, blood drawing, off-label compassionate drug use

Sponsor: Charite University, Berlin, Germany

In this project, the investigators are using iPSC lines derived from patients with Leigh syndrome that carry mutations in the mitochondrial (mtDNA) and in the nuclear DNA (nDNA) to reprogram them into neural progenitor cells and into dopaminergic neurons. The researchers are usin...

Ages not specified2 locations
Started Mar 2020Updated 1 year agoEst. Feb 2030 (~3y 4m)
Get Leigh Syndrome alerts by email

One email when something new happens for Leigh Syndrome, never a newsletter.

You'll get new recruiting trials, changes to trials, FDA decisions and condition news for Leigh Syndrome. Turn any of these off from the link in every email.

We never share your email. Unsubscribe anytime. Privacy policy · Check any health site
Find Leigh Syndrome trials near you, ranked by distance →
Active trial locations3 cities in the US

Trial Pipeline

Jan 2021 to Oct 2031
2021
2023
2025
2027
2029
2031
now
Phase 2
Observational
RecruitingOpening soonDelayed startTodayHover a bar for trial details
Need help understanding these trials?
Answers with sources, in plain English
Start withor ask
Run a Leigh Syndrome foundation or patient group?
You can put this live trial list on your own website. It updates itself, and it's free.
Get the embed code →

Data from ClinicalTrials.gov, U.S. National Library of Medicine.
Always talk to your doctor before considering a clinical trial.

Patient Communities

Connect with other Leigh Syndrome patients, caregivers, and advocacy groups across Facebook groups, Reddit communities, and YouTube channels. These patient communities offer peer support, shared experiences, caregiver resources, and real-time discussion about Leigh Syndrome treatments, clinical trial participation, and day-to-day disease management.

Find the right community
Answers with sources, in plain English
Start withor ask

Related Conditions

Conditions that share genes, symptoms or treatments with Leigh Syndrome, followed by others in the metabolic & lysosomal category. Patients with Leigh Syndrome may find relevant research, shared treatment pathways, or overlapping clinical trials among these related conditions.

Companies Developing Leigh Syndrome Treatments

3 pharmaceutical companies have Leigh Syndrome in their rare disease portfolio

Frequently Asked Questions About Leigh Syndrome